Regenerative Medical Technology Group Inc. (RMTG) Stock Price & Analysis
Regenerative Medical Technology Group Inc. (RMTG) — price $0.03386 (+12.87%), as of the Nov 18, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Regenerative Medical Technology Group Inc. · RMTG
Regenerative Medical Technology Group Inc. (RMTG) operates in the regenerative medicine sector, providing products, solutions, equipment, and training for stem cell therapies to medical professionals and patients globally.
Price as of Nov 18, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.03386 | |
| Change on the day | +12.87% | |
| 52-week range | $0.0189 – $0.125 | |
| Shares traded on the day | 130.0K |
Price & events
Other perspectives
Council score for Regenerative Medical Technology Group (RMTG): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
1 lens, 1 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Regenerative Medical Technology Group (RMTG), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Regenerative Medical Technology Group Inc. (RMTG) is the company analyzed here. It employs 1 people and is led by David Christensen. In Q2 FY2026 it reported revenue of $4M and net income of -$3M.
What do the latest results show for Regenerative Medical Technology Group (RMTG)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $4M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $4M | -$3M | -$0.22 (diluted) |
| Q1 FY2026 | $3M | -$876,274 | -$0.07 (diluted) |
| Q4 FY2025 | $2M | -$1M | -$0.11 (diluted) |
| Q3 FY2025 | $1M | -$4M | -$0.35 (diluted) |
What are the financial strengths and risks for Regenerative Medical Technology Group (RMTG)?
Short answer · as of
The distress and quality screens read Altman Z -24.76 · Piotroski F 5. Trailing ratios: ROE 27.3% · current ratio 0.05.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held RMTG in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported RMTG in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: RMTG Stock
These answers are editorial: 1 of these 8 answers is drawn from the RMTG research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is RMTG a good stock to buy?
Stock Expert AI does not rate RMTG buy, sell or hold. Regenerative Medical Technology Group Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the RMTG stock price today?
The last price recorded for Regenerative Medical Technology Group Inc. (RMTG), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What does Regenerative Medical Technology Group Inc. do?
Regenerative Medical Technology Group Inc. (RMTG) operates within the specialized field of regenerative medicine, focusing on stem cell therapies. The company provides a comprehensive suite of offerings, including essential products, innovative solutions, specialized equipment, and in-depth training to medical professionals and their teams.
What are the key factors to evaluate for RMTG?
Evaluate RMTG on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does RMTG data refresh on this page?
RMTG's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven RMTG's recent stock price performance?
Regenerative Medical Technology Group Inc. (RMTG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Operates in the high-growth regenerative medicine sector with increasing demand. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RMTG overvalued or undervalued right now?
Regenerative Medical Technology Group Inc. (RMTG) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research RMTG before investing?
Before investing in Regenerative Medical Technology Group Inc. (RMTG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 12 figures on this page — 7 from Financial Modeling Prep (FMP) and 5 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com